Legis Daily

To clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

USA115th CongressHR-6702| House 
| Updated: 10/9/2018
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (1)
Marsha Blackburn (Republican)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
DEA Enforcement and Authority Act of 2018 This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA). The bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a CSA violation. Specifically, it eliminates the requirement for an order to show cause to notify the registrant of the opportunity to submit a corrective action plan. Additionally, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat that harm will occur to probable cause to believe an imminent threat that harm or diversion will occur.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 5, 2018

Latest Companion Bill Action

S 115-2493
Introduced in Senate
Sep 5, 2018
Introduced in House
Sep 5, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 8, 2018
Referred to the Subcommittee on Health.
Oct 9, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • March 5, 2018

    Latest Companion Bill Action

    S 115-2493
    Introduced in Senate


  • September 5, 2018
    Introduced in House


  • September 5, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • September 8, 2018
    Referred to the Subcommittee on Health.


  • October 9, 2018
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Law Enforcement

Related Bills

  • S 115-2493: A bill to clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Administrative remediesDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrations

To clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

USA115th CongressHR-6702| House 
| Updated: 10/9/2018
DEA Enforcement and Authority Act of 2018 This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA). The bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a CSA violation. Specifically, it eliminates the requirement for an order to show cause to notify the registrant of the opportunity to submit a corrective action plan. Additionally, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat that harm will occur to probable cause to believe an imminent threat that harm or diversion will occur.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 5, 2018

Latest Companion Bill Action

S 115-2493
Introduced in Senate
Sep 5, 2018
Introduced in House
Sep 5, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 8, 2018
Referred to the Subcommittee on Health.
Oct 9, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • March 5, 2018

    Latest Companion Bill Action

    S 115-2493
    Introduced in Senate


  • September 5, 2018
    Introduced in House


  • September 5, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • September 8, 2018
    Referred to the Subcommittee on Health.


  • October 9, 2018
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (1)
Marsha Blackburn (Republican)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • S 115-2493: A bill to clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative remediesDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrations